NEW YORK, Oct 31 – Nanogen said Tuesday its third quarter revenues jumped 84 percent to $3.5 million from $1.9 million, with $545,000 stemming from sales of its NanoChip Molecular Biology Workstations and NanoChip cartridges.

In third quarter 1999, Nanogen did not post any revenues from sales of its products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.